Samjin Pharmaceuticals Market Cap

Samjin Pharmaceuticals has a market cap or net worth of 216.10 billion as of April 17, 2025. Its market cap has decreased by -17.28% in one year.

Market Cap

216.10B

Enterprise Value

n/a

Revenue

274.03B

Ranking

n/a

PE Ratio

10.20

Stock Price

17,460.00

Market Cap Chart

Since August 30, 1995, Samjin Pharmaceuticals's market cap has increased from 29.12B to 216.10B, an increase of 642.12%. That is a compound annual growth rate of 6.99%.

Market Cap History

Date	Market Cap	% Change
Apr 18, 2025	216.10B	-2.48%
Dec 30, 2024	221.61B	-19.69%
Dec 28, 2023	275.94B	-19.80%
Dec 29, 2022	344.07B	5.06%
Dec 30, 2021	327.51B	-3.49%
Dec 30, 2020	339.34B	9.22%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	74.66T
Celltrion	34.28T
ALTEOGEN	20.94T
Yuhan	8,636.87B
SK Biopharmaceuticals	8,207.23B
HLB Co., Ltd.	7,356.32B
LigaChem Biosciences	3,856.78B
Peptron	3,778.83B

Market Cap Rankings